{"id":"W2520692458","doi":"10.1016/j.ctrv.2016.09.001","title":"Post-gemcitabine therapy for patients with advanced pancreatic cancer – A comparative review of randomized trials evaluating oxaliplatin- and/or irinotecan-containing regimens","year":2016,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Medicine; Irinotecan; Oxaliplatin; Gemcitabine; Internal medicine; Oncology; Pancreatic cancer; Clinical trial; Randomized controlled trial; FOLFIRINOX; Population; Context (archaeology); Progression-free survival; Cancer; Colorectal cancer; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002467778,0.0006870846,0.003650476,0.001426593,0.0001481936,0.0008998498,0.0009439425,0.0006456827,0.003096017],"category_scores_gemma":[0.004714962,0.0003526749,0.004035616,0.001901121,0.0003034596,0.0007591126,0.0004806267,0.0009593035,0.0001687813],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006851482,"about_ca_system_score_gemma":0.001130802,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00116382,"about_ca_topic_score_gemma":0.004484836,"domain_scores_codex":[0.9989532,0.0003784927,0.0003764452,0.0001106698,0.0001401182,0.000040981],"domain_scores_gemma":[0.997767,0.001477073,0.0005604525,0.00003391294,0.0001218074,0.00003974463],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.007244007,0.000150412,0.0008707062,0.6325984,0.02750749,0.0001207883,0.0001240766,0.0003485889,0.001303195,0.0005008843,0.003271465,0.32596],"study_design_scores_gemma":[0.01622088,0.008131859,0.01921182,0.4008623,0.3695729,0.001593061,0.0006047654,0.0003848923,0.001768735,0.001755382,0.179757,0.0001365179],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001070475,0.9985127,0.0000437011,0.00006450214,0.00005544192,0.00004452,0.00004747308,0.000002045186,0.0001591643],"genre_scores_gemma":[0.01089915,0.9881912,0.0003242567,0.0003120554,0.00005351995,0.00004602181,0.00007962009,0.000002115818,0.00009202392],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003650476,"threshold_uncertainty_score":0.01305103,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.30522861975147,"score_gpt":0.5399468667520916,"score_spread":0.2347182470006216,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}